Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT - New York Stock Exchange, Inc. - US2244411052 - Common Stock - Currency: USD

52.25  -1.94 (-3.58%)

After market: 52.25 0 (0%)

Fundamental Rating

5

Taking everything into account, CXT scores 5 out of 10 in our fundamental rating. CXT was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT has a great profitability rating, there are quite some concerns on its financial health. CXT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
In the past year CXT had a positive cash flow from operations.
Each year in the past 5 years CXT has been profitable.
CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CXT has a Return On Assets of 7.71%. This is amongst the best in the industry. CXT outperforms 88.80% of its industry peers.
CXT has a better Return On Equity (17.29%) than 88.00% of its industry peers.
The Return On Invested Capital of CXT (12.05%) is better than 88.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 9.29%.
Industry RankSector Rank
ROA 7.71%
ROE 17.29%
ROIC 12.05%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 12.38%, CXT belongs to the best of the industry, outperforming 88.80% of the companies in the same industry.
CXT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 20.63%, CXT belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
In the last couple of years the Operating Margin of CXT has remained more or less at the same level.
Looking at the Gross Margin, with a value of 44.73%, CXT is in the better half of the industry, outperforming 78.40% of the companies in the same industry.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 20.63%
PM (TTM) 12.38%
GM 44.73%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
CXT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.61 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.61, CXT is in line with its industry, outperforming 41.60% of the companies in the same industry.
The Debt to FCF ratio of CXT is 4.45, which is a neutral value as it means it would take CXT, 4.45 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CXT (4.45) is better than 63.20% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that CXT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, CXT is not doing good in the industry: 82.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.45
Altman-Z 2.61
ROIC/WACC1.3
WACC9.27%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXT has a Current Ratio of 1.14. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.14, CXT is not doing good in the industry: 88.80% of the companies in the same industry are doing better.
A Quick Ratio of 0.88 indicates that CXT may have some problems paying its short term obligations.
CXT has a worse Quick ratio (0.88) than 82.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.88
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -2.22% in the last year.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
Looking at the last year, CXT shows a small growth in Revenue. The Revenue has grown by 6.86% in the last year.
CXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)-2.22%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-36.47%
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.70% yearly.
CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.76% yearly.
EPS Next Y-2.54%
EPS Next 2Y6.09%
EPS Next 3Y8.7%
EPS Next 5YN/A
Revenue Next Year6.56%
Revenue Next 2Y7.23%
Revenue Next 3Y7.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

CXT is valuated correctly with a Price/Earnings ratio of 13.19.
CXT's Price/Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 88.80% of the companies in the same industry.
When comparing the Price/Earnings ratio of CXT to the average of the S&P500 Index (26.03), we can say CXT is valued slightly cheaper.
A Price/Forward Earnings ratio of 10.87 indicates a reasonable valuation of CXT.
Based on the Price/Forward Earnings ratio, CXT is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
CXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.19
Fwd PE 10.87
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 88.80% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CXT is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.77
EV/EBITDA 8.57
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.09%
EPS Next 3Y8.7%

6

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.24%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.09, CXT pays a better dividend. On top of this CXT pays more dividend than 87.20% of the companies listed in the same industry.
With a Dividend Yield of 1.24, CXT pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

19.88% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP19.88%
EPS Next 2Y6.09%
EPS Next 3Y8.7%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (5/21/2025, 8:04:00 PM)

After market: 52.25 0 (0%)

52.25

-1.94 (-3.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners101.08%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner Change6.78%
Market Cap3.00B
Analysts81.82
Price Target85.51 (63.66%)
Short Float %9.69%
Short Ratio10.93
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP19.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.17)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-1.06%
Max EPS beat(2)0.6%
EPS beat(4)2
Avg EPS beat(4)-0.05%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.6%
EPS beat(8)6
Avg EPS beat(8)7.74%
EPS beat(12)9
Avg EPS beat(12)6.93%
EPS beat(16)13
Avg EPS beat(16)11.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)1.8%
Revenue beat(4)1
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)1.8%
Revenue beat(8)4
Avg Revenue beat(8)0.92%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.01%
PT rev (3m)-5.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.99%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)-6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.48%
Revenue NY rev (1m)4.83%
Revenue NY rev (3m)4.35%
Valuation
Industry RankSector Rank
PE 13.19
Fwd PE 10.87
P/S 2.02
P/FCF 17.77
P/OCF 14
P/B 2.81
P/tB N/A
EV/EBITDA 8.57
EPS(TTM)3.96
EY7.58%
EPS(NY)4.81
Fwd EY9.2%
FCF(TTM)2.94
FCFY5.63%
OCF(TTM)3.73
OCFY7.14%
SpS25.92
BVpS18.57
TBVpS-5.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.71%
ROE 17.29%
ROCE 16.81%
ROIC 12.05%
ROICexc 13.12%
ROICexgc 49.78%
OM 20.63%
PM (TTM) 12.38%
GM 44.73%
FCFM 11.35%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexcg growth 3Y39.7%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.45
Debt/EBITDA 1.91
Cap/Depr 52.3%
Cap/Sales 3.05%
Interest Coverage 6.95
Cash Conversion 54.41%
Profit Quality 91.64%
Current Ratio 1.14
Quick Ratio 0.88
Altman-Z 2.61
F-Score4
WACC9.27%
ROIC/WACC1.3
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.22%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-36.47%
EPS Next Y-2.54%
EPS Next 2Y6.09%
EPS Next 3Y8.7%
EPS Next 5YN/A
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next Year6.56%
Revenue Next 2Y7.23%
Revenue Next 3Y7.76%
Revenue Next 5YN/A
EBIT growth 1Y6.75%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year15.53%
EBIT Next 3Y12.32%
EBIT Next 5YN/A
FCF growth 1Y-31.2%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-22.51%
OCF growth 3Y-8.23%
OCF growth 5YN/A